March 19, 2018 / 8:27 PM / a month ago

BRIEF-Atyr Pharma Q4 Loss Per Share $0.39

March 19 (Reuters) - Atyr Pharma Inc:

* ATYR PHARMA ANNOUNCES FOURTH QUARTER AND YEAR-END 2017 OPERATING RESULTS AND PROVIDES CORPORATE UPDATE

* ‍ATYR EXPECTS THAT ITS CASH, CASH EQUIVALENTS AND INVESTMENTS WILL BE SUFFICIENT TO FUND ITS ANTICIPATED OPERATIONS INTO Q3 OF 2019​

* QTRLY LOSS PER SHARE $0.39

* Q4 EARNINGS PER SHARE VIEW $-0.41 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below